Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Other Accumulated Expenses (2019 - 2025)

Outset Medical (OM) has disclosed Other Accumulated Expenses for 6 consecutive years, with $4.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses rose 31.72% to $4.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.1 million, a 31.72% increase, with the full-year FY2025 number at $4.1 million, up 31.72% from a year prior.
  • Other Accumulated Expenses was $4.1 million for Q4 2025 at Outset Medical, up from $3.1 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $7.1 million in Q4 2022 to a low of $3.1 million in Q4 2024.
  • A 5-year average of $5.1 million and a median of $5.2 million in 2024 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: surged 187.13% in 2021, then crashed 46.36% in 2024.
  • Outset Medical's Other Accumulated Expenses stood at $4.0 million in 2021, then surged by 76.97% to $7.1 million in 2022, then dropped by 18.96% to $5.8 million in 2023, then crashed by 46.36% to $3.1 million in 2024, then surged by 31.72% to $4.1 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Other Accumulated Expenses are $4.1 million (Q4 2025), $3.1 million (Q4 2024), and $5.2 million (Q1 2024).